albendazole has been researched along with Colorectal Cancer in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " dosing (ABZ, 150 mg/kg) led to the highest degree of tumor growth suppression (P<0." | 5.33 | Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. ( Akhter, J; Lu, Y; Morris, DL; Pourgholami, MH; Wang, L, 2005) |
| "Our preclinical studies have shown that the widely used antiparasitic drug albendazole has potent antiproliferative activity against colorectal cancer (CRC) and hepatocellular carcinoma (HCC)." | 5.09 | Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia. ( Jourdan, JL; Morris, DL; Pourgholami, MH, 2001) |
| "The interactions between ABZ and microtubule-binding agents, paclitaxel, vinblastine, colchicine, and 2-methoxyestradiol were characterized using median effect analysis method in HCT-116 colorectal cancer cells and DU145 prostate cancer cell line." | 3.79 | Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice. ( Ehteda, A; Galettis, P; Morris, DL; Pillai, K, 2013) |
| "Albendazole (ABZ) is a microtubule depolymerizing agent with a remarkable activity against a variety of tumor cells in vitro and in vivo." | 1.38 | Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice. ( Chu, SW; Ehteda, A; Galettis, P; Morris, DL; Pillai, K, 2012) |
| " dosing (ABZ, 150 mg/kg) led to the highest degree of tumor growth suppression (P<0." | 1.33 | Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. ( Akhter, J; Lu, Y; Morris, DL; Pourgholami, MH; Wang, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehteda, A | 2 |
| Galettis, P | 2 |
| Pillai, K | 2 |
| Morris, DL | 4 |
| Taranejoo, S | 1 |
| Janmaleki, M | 1 |
| Pachenari, M | 1 |
| Seyedpour, SM | 1 |
| Chandrasekaran, R | 1 |
| Cheng, W | 1 |
| Hourigan, K | 1 |
| Park, S | 1 |
| Kim, YS | 1 |
| Kim, YJ | 1 |
| Kyung, SY | 1 |
| Park, JW | 1 |
| Jeong, SH | 1 |
| Lee, SP | 1 |
| Chu, SW | 1 |
| Pourgholami, MH | 2 |
| Akhter, J | 1 |
| Wang, L | 1 |
| Lu, Y | 1 |
| Jourdan, JL | 1 |
1 trial available for albendazole and Colorectal Cancer
| Article | Year |
|---|---|
Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia.
Topics: Adult; Aged; Albendazole; Antineoplastic Agents; Biomarkers, Tumor; Blood Cell Count; Carcinoembryon | 2001 |
5 other studies available for albendazole and Colorectal Cancer
| Article | Year |
|---|---|
Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice.
Topics: 2-Methoxyestradiol; Albendazole; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 2013 |
Dual effect of F-actin targeted carrier combined with antimitotic drug on aggressive colorectal cancer cytoskeleton: Allying dissimilar cell cytoskeleton disrupting mechanisms.
Topics: Actins; Albendazole; Antimitotic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Colorectal Neopl | 2016 |
Toxocariasis masquerading as liver and lung metastatic nodules in patents with gastrointestinal cancer: clinicopathologic study of five cases.
Topics: Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Biopsy; Colorectal Neoplasms; Diagnosis, | 2012 |
Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetic Acid; Albendazole; Animals; beta-Cyclodextrins; Chromatogr | 2012 |
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Topics: Albendazole; Animals; Anthelmintics; Apoptosis; Carcinoma; Colorectal Neoplasms; Humans; In Situ Nic | 2005 |